Previous 10 | Next 10 |
2023-04-03 10:02:08 ET Gainers: Heska ( HSKA ) +20% . Heron Therapeutics ( HRTX ) +19% . InterCure ( INCR ) +17% . Innate Pharma ( IPHA ) +15% . Apellis Pharmaceuticals ( APLS ) +14% . Losers: OncoSec Medical ( ONCS...
2023-04-03 09:36:17 ET Heron Therapeutics ( NASDAQ: HRTX ) appointed Craig Collard as CEO, effective immediately, succeeding Barry Quart, Pharm.D., who has stepped down as CEO and Chairman of the Board. The board elected Adam Morgan ...
Heron Therapeutics Announces New CEO and Board Chairman PR Newswire Craig Collard Appointed CEO Adam Morgan Named Chairman of the Board SAN DIEGO , April 3, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (NASDAQ: HRTX ) ("Heron" or the "Company...
2023-03-28 05:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-03-24 11:31:28 ET Heron Therapeutics ( NASDAQ: HRTX ) stock fell ~12% on Friday despite Q4 results beat estimates as potential headwinds related to the label and the device delivery of Zynrelef lingered. Net loss narrowed to -$19.87M, compared to -$54.65Min Q4 ...
2023-03-24 10:01:43 ET Gainers: Dermata Therapeutics ( DRMA ) +40% . GH Research ( GHRS ) +27% . Vaccitech ( VACC ) +25% . Cosmos Health ( COSM ) +10% . Assure ( IONM ) +6% . Losers: BridgeBio Pharma ( BBIO ) -9%...
2023-03-24 08:36:57 ET The futures were pointing to a decline at the start of Friday's trading. Stocks gained the day before in choppy trading, as strength in technology overcame weakness in other parts of the market. Here are some stocks to watch on Friday: Deutsche Bank ( NYSE: ...
2023-03-24 00:49:20 ET The following slide deck was published by Heron Therapeutics, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Heron Therapeutics, Inc. 2022 Q4 - Results - Earnings Call Presentation
2023-03-23 21:08:06 ET Heron Therapeutics, Inc. (HRTX) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants David Szekeres – Executive Vice President, Chief Operating Officer Barry Quart – Chairman and Chief Executive Officer ...
2023-03-23 16:06:31 ET Heron Therapeutics press release ( NASDAQ: HRTX ): Q4 GAAP EPS of -$0.17 beats by $0.15 . Revenue of $30.03M (+45.4% Y/Y) beats by $2.79M . As of December 31, 2022, Heron had cash, cash equivalents and short-term investments of ...
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 30, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company...
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System PR Newswire SAN DIEGO , July 15, 2024 /PRNewswire/ -- Heron Therapeutics, Inc....
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire -The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 ...